125 related articles for article (PubMed ID: 11074131)
1. Three-year follow-up of [CA-125, CA 19-9, CA 15-3, SIL-2R, IL-6, IL-la, TNF-a, sCD8 and sCD4] levels in a woman with severe endometriosis.
Matalliotakis IM; Neonaki MA; Panidis DK; Goumenou AG; Koumantakis EE
Eur J Obstet Gynecol Reprod Biol; 2000 Dec; 93(2):127-9. PubMed ID: 11074131
[TBL] [Abstract][Full Text] [Related]
2. Soluble serum interleukin-2 receptor, interleukin-6 and interleukin-1a in patients with endometriosis and in controls.
Koumantakis E; Matalliotakis I; Neonaki M; Froudarakis G; Georgoulias V
Arch Gynecol Obstet; 1994; 255(3):107-12. PubMed ID: 7979562
[TBL] [Abstract][Full Text] [Related]
3. Patterns of cytokines and soluble cellular receptors in the sera of children with acute chagas' disease.
Moretti E; Basso B; Cervetta L; Brigada A; Barbieri G
Clin Diagn Lab Immunol; 2002 Nov; 9(6):1324-7. PubMed ID: 12414768
[TBL] [Abstract][Full Text] [Related]
4. Changes in immunologic variables (TNF-a, sCD8 and sCD4) during danazol treatment in patients with endometriosis.
Matalliotakis I; Neonaki M; Zolindaki A; Hassan E; Georgoulias V; Koumantakis E
Int J Fertil Womens Med; 1997; 42(3):211-4. PubMed ID: 9222806
[TBL] [Abstract][Full Text] [Related]
5. Changes in levels of soluble T-cell activation markers, sIL-2R, sCD4 and sCD8, in relation to disease exacerbations in patients with systemic lupus erythematosus: a prospective study.
Spronk PE; ter Borg EJ; Huitema MG; Limburg PC; Kallenberg CG
Ann Rheum Dis; 1994 Apr; 53(4):235-9. PubMed ID: 8203951
[TBL] [Abstract][Full Text] [Related]
6. Circulating levels of cytokines and soluble cytokine receptors in various T-cell malignancies.
Raziuddin S; Sheikha A; Abu-Eshy S; al-Janadi M
Cancer; 1994 May; 73(9):2426-31. PubMed ID: 8168046
[TBL] [Abstract][Full Text] [Related]
7. Extracts of Salvia miltiorrhiza Bunge on the cytokines of rat endometriosis models.
Zhou ZH; Weng Q; Zhou JH; Zhou J
Afr J Tradit Complement Altern Med; 2012; 9(3):303-14. PubMed ID: 23983360
[TBL] [Abstract][Full Text] [Related]
8. Soluble interleukin-2 receptor (sIL-2R) is a marker of disease activity in psoriasis: a comparison of sIL-2R, sCD27, sCD4, sCD8 and sICAM-1.
De Rie MA; Zonneveld IM; Witkamp L; Van Lier RA; Out TA; Bos JD
Acta Derm Venereol; 1996 Sep; 76(5):357-60. PubMed ID: 8891007
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of helper factors (IL-1 alpha, IL-1 beta and IL-6), T-cell products (sCD4 and sCD8), sIL-2R and beta 2-microglobulin in patients with B-CLL and benign B lymphocytosis.
Aguilar-Santelises M; Loftenius A; Ljungh C; Svenson SB; Andersson B; Mellstedt H; Jondal M
Leuk Res; 1992; 16(6-7):607-13. PubMed ID: 1386130
[TBL] [Abstract][Full Text] [Related]
10. Behavior of serum soluble interleukin-2 receptor, soluble CD8 and soluble CD4 in the early phases of acute pancreatitis.
Pezzilli R; Billi P; Gullo L; Beltrandi E; Maldini M; Mancini R; Incorvaia L; Miglioli M
Digestion; 1994; 55(4):268-73. PubMed ID: 8063032
[TBL] [Abstract][Full Text] [Related]
11. Serum TNF-alpha, sCD8 and sIL-2R levels in childhood tuberculosis.
Barlan IB; Başaran MM; Bakir M; Tükenmez F; Bekiroğlu N
Infection; 1995; 23(4):237-9. PubMed ID: 8522383
[TBL] [Abstract][Full Text] [Related]
12. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue.
Kurane I; Innis BL; Nimmannitya S; Nisalak A; Meager A; Janus J; Ennis FA
J Clin Invest; 1991 Nov; 88(5):1473-80. PubMed ID: 1939640
[TBL] [Abstract][Full Text] [Related]
13. Soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in hematologic malignancies.
Srivastava MD; Srivastava A; Srivastava BI
Leuk Lymphoma; 1994 Jan; 12(3-4):241-51. PubMed ID: 7909467
[TBL] [Abstract][Full Text] [Related]
14. Elevated soluble CD8 antigen and soluble interleukin-2 receptors in the sera of patients with juvenile rheumatoid arthritis.
Lipnick RN; Sfikakis PP; Klipple GL; Tsokos GC
Clin Immunol Immunopathol; 1993 Jul; 68(1):64-7. PubMed ID: 8513595
[TBL] [Abstract][Full Text] [Related]
15. Soluble interleukin-2 receptor, CD4 and CD8 levels in melanoma: a longitudinal study.
Fierro MT; Lisa F; Novelli M; Bertero M; Bernengo MG
Dermatology; 1992; 184(3):182-9. PubMed ID: 1392109
[TBL] [Abstract][Full Text] [Related]
16. Cytokines (IL-6, TNF-alpha, IL-1alpha) and soluble interleukin-2 receptor as serum tumor markers in multiple myeloma.
Filella X; Blade J; Guillermo AL; Molina R; Rozman C; Ballesta AM
Cancer Detect Prev; 1996; 20(1):52-6. PubMed ID: 8907203
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of selected angiogenic and inflammatory markers in endometriosis before and after danazol treatment.
Szubert M; Suzin J; Duechler M; Szuławska A; Czyż M; Kowalczyk-Amico K
Reprod Fertil Dev; 2014 Mar; 26(3):414-20. PubMed ID: 23544741
[TBL] [Abstract][Full Text] [Related]
18. Serum markers of T-cell activation in relapses of Wegener's granulomatosis.
Stegeman CA; Tervaert JW; Huitema MG; Kallenberg CG
Adv Exp Med Biol; 1993; 336():389-92. PubMed ID: 8296642
[TBL] [Abstract][Full Text] [Related]
19. Soluble interleukin 2 receptor and soluble CD8 levels in previously treated human immunodeficiency virus-negative hemophiliacs multiply transfused with a monoclonal antibody-purified factor VIII concentrate.
Smid WM; Martens A; van der Meer J; Hegge-Paping CS; Halie MR
Transfusion; 1997 Jan; 37(1):86-9. PubMed ID: 9024495
[TBL] [Abstract][Full Text] [Related]
20. Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus.
Doganay S; Evereklioglu C; Er H; Türköz Y; Sevinç A; Mehmet N; Savli H
Eye (Lond); 2002 Mar; 16(2):163-70. PubMed ID: 11988817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
